These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19783884

  • 1. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [Abstract] [Full Text] [Related]

  • 2. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
    Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero LM.
    Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
    [Abstract] [Full Text] [Related]

  • 3. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH, Park HY, Kang JW, Park JS, Shin KJ, Kim CH, Suk KT, Baik GH, Kim JB, Kim DJ, Lee HY.
    Hepatogastroenterology; 2012 Oct; 59(120):2548-51. PubMed ID: 23178621
    [Abstract] [Full Text] [Related]

  • 4. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
    Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, Lee FY, Lee SD.
    Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P.
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina MV, Hernando A, Clemente G, Matilla A, Nuñez O, Bañares R.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):841-8. PubMed ID: 17373923
    [Abstract] [Full Text] [Related]

  • 14. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
    Liver Transpl; 2008 Jun 01; 14(6):837-44. PubMed ID: 18508377
    [Abstract] [Full Text] [Related]

  • 15. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb 01; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 16. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep 01; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 17. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr 01; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 18. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C, Lastra P, Rincón D, Catalina V, Bañares R.
    Scand J Gastroenterol; 2012 Feb 01; 47(2):204-11. PubMed ID: 22242615
    [Abstract] [Full Text] [Related]

  • 19. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK, Lee JS, Kim NH, Kim KA, Moon YS, Oh MK.
    Korean J Hepatol; 2007 Mar 01; 13(1):51-60. PubMed ID: 17380075
    [Abstract] [Full Text] [Related]

  • 20. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul 01; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.